No Data
HEC CJ PHARM (01558.HK) will hold a Board of Directors meeting on March 28 to approve the annual performance.
On March 18, Gelonghui announced that HEC CJ PHARM (01558.HK) will hold a Board of Directors meeting on March 28, 2025, to approve the annual performance announcement for the company and its subsidiaries for the year ending December 31, 2024, and to consider the proposal for the final dividend distribution (if any).
Should You Be Concerned About Guangdong HEC Technology Holding Co., Ltd's (SHSE:600673) ROE?
Guangdong Hec Technology Holding (600673.SH): A subsidiary plans to establish a joint venture with Zhongji Innolight to engage in the R&D, production, and sales of liquid thermal management components and system solutions.
On February 28, Glonghui reported that Guangdong Hec Technology Holding (600673.SH) announced that its wholly-owned subsidiary, Guangdong Hec Liquid Cooling Technology, signed a "Liquid Cooling Investment Cooperation Agreement" with Zhongji Innolight. Both parties plan to jointly invest in establishing a joint venture company in Guangzhou, engaged in the research and development, production, and sales of liquid thermal management components and system solutions. The registered capital of the joint venture company is 100 million yuan, of which Guangdong Hec Liquid Cooling Technology intends to contribute 49 million yuan, accounting for 49% of the registered capital; Zhongji Innolight intends to contribute 51 million yuan, accounting for 51% of the registered capital. With the rapid iteration of AI technology and the explosive growth of computing power demand.
HAITONG INT'L: The supply and demand patterns and market opportunities under the tightening of refrigerant quotas between China and India.
The export of refrigerants between China and India shows a divergence, with leading enterprises consolidating their advantages through Industry Chain integration.
Guangdong Hec Technology Holding chooses Huawei Cloud Computing Service for business innovation based on DeepSeek.
Recently, Guangdong Hec Technology Holding selected Huawei Cloud Rising AI Cloud Computing Service to integrate the full version of the DeepSeek large model into the HEC-Finder platform and the group knowledge base platform to pursue innovation in pharmaceutical research and development.
The AI Medical "technology + scene" ecosystem continues to improve, and HEC CJ PHARM (01558) is expected to lead a new wave of Innovative Drugs development.
As one of the pioneers in the domestic AI Medical field, HEC CJ PHARM (01558) has chosen to combine self-research with collaboration, fully tapping into the enormous potential of AI technology to empower pharmaceutical innovation, providing a benchmark model of cost reduction and efficiency improvement for the Innovative Drugs Industry.
Should We Be Cautious About Guangdong HEC Technology Holding Co., Ltd's (SHSE:600673) ROE Of 2.8%?
